Bird flu one mutuation from human threat, study finds
A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
![Dairy cows in Wisconsin](https://cdn.mos.cms.futurecdn.net/tvvQeNEQyALHuSThgxngzk-1280-80.jpg)
What happened
A single genetic mutation could turn the H5N1 avian flu virus infecting U.S. dairy herds into a version transmissible between humans, researchers at Scripps Research Institute reported Thursday in the journal Science.
Who said what
The H5N1 strain that started sweeping through dairy farms in March has infected 58 people working with infected cattle and poultry, the CDC said, though only with mild symptoms and no known human-to-human transmission. "All that can change if the virus mutates in the wrong way," The Washington Post said. The Scripps team found that one genetic tweak could enable the hemagglutinin proteins, or spikes, on the virus to latch onto and penetrate human respiratory cells, allowing viral spread among people.
What next?
The study is "significant, but it shouldn't cause alarm," Emory University virologist Anice Lowen said to NPR. There are likely "other changes a virus would need to go through to efficiently transmit in humans and cause a pandemic," though the massive "potential human exposure out there" does pose a "great risk" of such mutation. "If there is a bird flu pandemic soon," columnist Zeynep Tufekci said last week in The New York Times, "it will be among the most foreseeable catastrophes in history."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Baltic States unplug from Russian grid, join EU's
Speed Read Estonia, Latvia and Lithuania are disconnecting from the Soviet-era electricity grid to join the EU's network
By Peter Weber, The Week US Published
-
Trump team aims to shut consumer finance watchdog
Speed Read The Consumer Financial Protection Bureau was established after the 2008 financial crisis to investigate corporate fraud and protect consumers
By Peter Weber, The Week US Published
-
Today's political cartoons - February 10, 2025
Cartoons Monday's cartoons - out of the right field, he sells sea scams, and more
By The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Sperm cells can carry past trauma in their DNA
Under the radar Your parent's past may be affecting your future
By Devika Rao, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
Why is the FDA slow to ban food additives?
Today's big question A legal loophole lets things slide
By Devika Rao, The Week US Published